Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3104102 | 0.80 | LMNA (0.41) | LMNAPTPN1ALDH1A1 | |
| SCHEMBL4881453 | 0.78 | ALDH1A1 (0.42) | LMNAPTPN1ALDH1A1 | |
| SCHEMBL52683 | 0.77 | LMNA (0.30) | LMNA | |
| SCHEMBL15922644 | 0.75 | ALDH1A1 (0.35) | LMNAPTPN1ALDH1A1 | |
| SCHEMBL1052850 | 0.74 | ALDH1A1 (0.38) | LMNAPTPN1ALDH1A1 | |
| SCHEMBL9720187 | 0.72 | ALDH1A1 (0.39) | LMNAPTPN1ALDH1A1 | |
| SCHEMBL1053416 | 0.72 | ALDH1A1 (0.36) | LMNAALDH1A1 | |
| SCHEMBL1051714 | 0.71 | LMNA (0.39) | LMNAALDH1A1 | |
| SCHEMBL7247429 | 0.70 | TRPA1 (0.38) | LMNAPTPN1ALDH1A1 | |
| SCHEMBL5269000 | 0.70 | ALDH1A1 (0.35) | LMNAPTPN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | CD2BP2, DCLRE1A, EPCAM | LMNA 1970/4885PTPN1 3907/4885ALDH1A1 618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.